Neumora Therapeutics Inc.

Address
260 Arsenal Place Suite 1

Sponsor Overview

assignment
2
sponsored trials
science
1
molecule
location_city
32
research centres
public
7
countries
person_search
34
investigators

Specializations

Major Depressive Disorder

Neumora Therapeutics Inc. focuses its clinical research on major depressive disorder, with studies centered on symptom reduction and the ongoing management of depressive illness in adults.

  • Depression symptom control
  • Adult psychiatry
  • Mood disorder treatment

The sponsor’s trial portfolio is concentrated in psychiatric drug development for depression-related conditions.

Kappa Opioid Receptor Antagonism

Its research activity includes therapies based on kappa opioid receptor antagonism, reflecting interest in neurobiological targets linked to depressive symptoms.

  • Neuropsychiatric targets
  • Receptor-based antidepressant mechanisms
  • Central nervous system therapeutics

This area connects molecular neuropharmacology with treatment development for mood disorders.

Long-term Safety and Tolerability

Neumora also funds research into the extended use of investigational psychiatric therapies, with attention to safety, tolerability, and sustained treatment experience in people with depression.

  • Long-term treatment monitoring
  • Psychiatric medication safety
  • Chronic depression care

The clinical focus includes maintaining treatment suitability over time in major depressive disorder.

Sponsored Trials

Trial Name Country Status
Evaluation of NMRA-335140 Efficacy in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled StudyBulgaria BulgariaCzechia CzechiaFinland FinlandFrance FranceGermany GermanyPoland PolandSweden SwedenNot Recruiting
Long-term Evaluation of NMRA-335140 for Safety and Efficacy in Major Depressive Disorder PatientsBulgaria BulgariaCzechia CzechiaFinland FinlandFrance FranceGermany GermanyPoland PolandSweden SwedenNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
91%
Return partnership rate
29 of 32 sites collaborated multiple times

This sponsor has worked with 32 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders2 trials
    150 other sponsors

Partnered Research Centres

32 centres
location_city
assignment39
A-Shine s.r.o.
Address
Sumavska 2, Vychodni Predmesti, 301 00 Pilsen
Learn morearrow_forward
location_city
assignment10
Brain-Soultherapy s.r.o.
Address
K Nemocnici 1904, 272 01 Kladno
Learn morearrow_forward
location_city
assignment2
Centre Hospitalier Georges Mazurelle- EPSM Mazurelle
Address
Rue d'Aubigny, 85000 La Roche sur Yon
Learn morearrow_forward
location_city
assignment6
Centre Hospitalier Henri Laborit
Address
370 Avenue Jacques Coeur, Cs 10587, 86021 Poitiers
Learn morearrow_forward
location_city
assignment494
Centre Hospitalier Regional D'Angers
Address
4 Rue Larrey, 49100 Angers
Learn morearrow_forward
location_city
assignment760
Centre Hospitalier Universitaire De Montpellier
Address
80 Avenue Augustin Fliche, 34295 Montpellier
Learn morearrow_forward
Page 1 of 6

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Neumora Therapeutics Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.